Turner Sendromlu 40 Vakanın Klinik Özellikleri

Yıl 2010, Cilt: 10 Sayı: 1, 29 - 32, 01.01.2010

İhsan Esen Mehmet Sadi Vidinlisan Fatma Demirel Halil İbrahim Yakut

https://doi.org/10.5222/j.child.2010.029

Öz

Amaç: Turner sendromlu hastaların fiziksel özellikleri, sitogenetik bulguları ve otoimmün hastalıklardan Hashimoto tiroiditi ve çölyak hastalığının sıklığını araştırmak amaçlandı. Gereç ve Yöntem: Turner sendromu tanılı 40 hastanın yaş ortalaması 13.9±3.9 yıl 5.2-20.2 dosyası geriye dönük olarak tarandı. Hastalar klinik ve sitogenetik özellikleri yönünden değerlendirildi. Ayrıca otoimmün hastalıklardan Hashimoto tiroiditi ve çölyak hastalığı araştırıldı. Final boyuna ulaşmış hastaların boylarının ebeveyn boyları ile olan ilişkisi irdelendi.Bulgular: Yirmi bir hastanın 45,X % 52.5 , 8 hastanın mozaik tipte % 20.0 olduğu geriye kalan 11 hastanın % 27.5 ise X kromozomuna ait değişik anomaliler taşıdığı görüldü. Vakaların boy standart sapmalarının ortalaması -4.41±1.10 idi. Final boyuna ulaşmış dokuz hastanın boy ortalaması 141.7±5.8 cm 133.5-151.6 , boy SDS ortalaması -3.61±1.00 [ -5.04 - -1.93 ] olarak saptandı. Bu hastaların boyları ile hedef boyları ve anne boyları arasında korelasyon saptanmadı [Sırası ile r = 0.486 p=0.129 ve r=0.461 p=0.153 ]. Dört hastada anti TPO, üç hastada anti Tg pozitifliği saptandı. Subklinik hipotiroidisi olan bir hasta dışında tüm hastaların tiroid fonksiyon testleri normal sınırlardaydı. Hem anti Tg hem anti TPO pozitifliği olan bir hastanın subklinik hipotiroidisi olduğu gözlendi. On iki hastada % 30 anti gliadin IgA ve/veya anti endomisyum antikor pozitifliği saptandı ve çölyak hastalığı yönünden biyopsi ile değerlendirildi. Hastalarımızın biyopsi örneklerinde patoloji bulgu saptanmadı.Sonuç: Vakaların fenotipik bulguları, taşıdıkları sitogenetik anomaliler ile korele bulundu. 45,X karyotipine sahip hastalarda klinik bulguların daha belirgin olduğu saptandı. Otoimmün hastalık sıklığının yaşla arttığı göz önünde bulundurularak Turner sendromlu hastaların otoimmün hastalıklar açısından periyodik aralıklarla taranmasının uygun olacağı düşünüldü

Anahtar Kelimeler

Çölyak hastalığı, Hashimoto tiroiditi, Turner sendromu

Clinical Fatures of 40 Cases With Turner Syndrome

Öz

Objectives: The aim of this study is to investigate cytogenetic and physical findings, and to determine frequency of Hashimoto’s thyroiditis and celiac disease in patients with Turner syndrome TS . Material and Method: The medical records of 40 patients with TS whose mean age was 13.9±3.9 year, were retrospectively reviewed. The diagnosis of TS was based on cytogenetic findings. Each patient was screened for thyroid abnormalities and celiac disease. The heights of patients who reached final height were evaluated according to their mother’s heights and mid-parental heights. Results: The karyotype was 45,X in 21 patients 52.5 % , mosaic in 8 patients 20.0 % and structural disturbances in 10 patients 27.5 % . The average of SD scores of patient’s heights was -4.41±1.10. The average of heights of eleven patients who reached final height was 141.7±5.8 cm. No significant correlation was found between heights of patients with their mother’s heights and mid-parental heights. Patients who have karyotype 45,X presents with severe clinical manifestations. Four patients were anti TPO positive and three patients were anti Tg positive. All patients had normal thyroid function except one who has subclinical hypothyroidism. Twelve patients who were either anti gliadin IgA or anti endomisyum positive, subsequently were investigated with intestinal biopsy, none of them manifested histological findings of celiac disease. Conclusion: The severity of physical features of patients with TS was associated with cytogenetic findings. Because of the prevalence of autoimmune diseases increases with advancing age, patients with TS must screen for Hashimoto’s thyroiditis and celiac disease periodically.

Anahtar Kelimeler

Celiac disease, Hashimoto’s thyroditis, Turner syndrome

Kaynakça

• 1. Rapaport R. Hypofunction of the Ovaries. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson Textbook of Pediatrics. 18th ed. Philadephia: Saunders 2008: 2316-40.
• 2. Saenger P. Turner Syndrome. In: Sperling MA. Eds. Pediatric Endocrinology 3 rd ed. Philadelphia: Saunders 2008: 610-61.
• 3. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40:1-19.
• 4. Pai GS, Leach DC, Weiss L, Wolf C, Van Dyke DL. Thyroid abnormalities in 20 children with Turner syndrome. J Pediatr 1977; 91:267-9.
• 5. Ivarsson SA, Ericsson UB, Nilsson KO, et al. Thyroid autoantibodies, Turner’s syndrome and growth hormone therapy. Acta Paediatr 1995; 84:63-5.
• 6. Fukuda I, Hizuka N, Kurimoto M, et al. Autoimmune thyroid diseases in 65 Japanese women with Turner syndrome. Endocr J 2009; 56:983-6.
• 7. Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938; 23:566-74.
• 8. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006; 91:3897- 902.
• 9. Bereket A, Turan S, Elçioğlu N, et al. Adult height in Turkish patients with Turner syndrome without growth hormone treatment. Turk J Pediatr 2008; 50:415-7.
• 10. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F. Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006; 95:1635-41.
• 11. Rochiccioli P, David M, Malpuech G, et al. Study of final height in Turner’s syndrome: ethnic and genetic influences. Acta Paediatr 1994; 83:305-8.
• 12. Torfs CP, van den Berg BJ, Oechsli FW, Christianson RE. Thyroid antibodies as a risk factor for Down syndrome and other trisomies. Am J Hum Genet 1990; 47:727-34.
• 13. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264:1422-5.
• 14. Livadas S, Xekouki P, Fouka F, et al. Prevalence of thyroid dysfunction in Turner’s syndrome: a long-term follow-up study and brief literature review. Thyroid 2005; 15:1061-6.
• 15. Chiovato L, Larizza D, Bendinelli G, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner’s syndrome. Eur J Endocrinol 1996; 134:568-75.
• 16. Radetti G, Mazzanti L, Paganini C, et al. Frequency, clinical and laboratory features of thyroiditis in girls with Turner’s syndrome. The Italian Study Group for Turner’s Syndrome. Acta Paediatr 1995; 84:909-12.
• 17. Chiovato L, Larizza D, Bendinelli G, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner’s syndrome. Eur J Endocrinol 1996; 134:568-75.
• 18. Sylvén L, Hagenfeldt K, Bröndum-Nielsen K, von Schoultz B. Middle-aged women with Turner’s syndrome. Medical status, hormonal treatment and social life. Acta Endocrinol (Copenh) 1991; 125:359-65.
• 19. El-Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K. Hypothyroidism is common in turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab 2005; 90:2131-5.
• 20. Ivarsson SA, Carlsson A, Bredberg A, et al. Prevalence of coeliac disease in Turner syndrome. Acta Paediatr 1999; 88:933-6.
• 21. Schewior S, Brand M, Santer R. Celiac disease and selective IgA deficiency in a girl with atypical Turner syndrome. J Pediatr Gastroenterol Nutr 1999; 28:353-4.
• 22. Bonamico M, Pasquino AM, Mariani P, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab 2002; 87:5495-8.